{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:37:18Z","timestamp":1784975838141,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL146111"],"award-info":[{"award-number":["R01HL146111"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL158052"],"award-info":[{"award-number":["R01HL158052"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL153835"],"award-info":[{"award-number":["R01HL153835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["T32HL094274"],"award-info":[{"award-number":["T32HL094274"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtm.2024.101233","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T16:34:59Z","timestamp":1710174899000},"page":"101233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy"],"prefix":"10.1016","volume":"32","author":[{"given":"Xueyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Maj","family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-6953","authenticated-orcid":false,"given":"Michael S.","family":"Kapiloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101233_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated Cardiomyopathy: Genetic Determinants and Mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2024.101233_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.116.027134","article-title":"Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future","volume":"136","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.omtm.2024.101233_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omtm.2024.101233_bib4","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/CIRCRESAHA.119.313569","article-title":"Novel Therapies for Prevention and Early Treatment of Cardiomyopathies","volume":"124","author":"Repetti","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2024.101233_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101233_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(08)80028-4","article-title":"The cellular basis of dilated cardiomyopathy in humans","volume":"27","author":"Beltrami","year":"1995","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtm.2024.101233_bib7","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.119.044805","article-title":"Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure","volume":"142","author":"Li","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.omtm.2024.101233_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109357","article-title":"mAKAPbeta signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling","volume":"63","author":"Dodge-Kafka","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.omtm.2024.101233_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41434-022-00321-w","article-title":"Targeting mAKAPbeta expression as a therapeutic approach for ischemic cardiomyopathy","volume":"30","author":"Martinez","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101233_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yexcr.2004.10.009","article-title":"Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope","volume":"303","author":"Pare","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omtm.2024.101233_bib18","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1074\/jbc.M109.034868","article-title":"cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3","volume":"285","author":"Dodge-Kafka","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101233_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.107.148379","article-title":"Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity","volume":"101","author":"Rajan","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2024.101233_bib11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.116.024482","article-title":"Long-Term Biased beta-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy","volume":"135","author":"Ryba","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.omtm.2024.101233_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1185261","article-title":"Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump","volume":"10","author":"Kho","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.omtm.2024.101233_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI24159","article-title":"Altered intracellular Ca2+ handling in heart failure","volume":"115","author":"Yano","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101233_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacbts.2019.05.011","article-title":"Epigenetics in Cardiac Hypertrophy and Heart Failure","volume":"4","author":"Liu","year":"2019","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.omtm.2024.101233_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omtm.2024.101233_bib16","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/s41598-023-30514-1","article-title":"A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling","volume":"13","author":"Nijholt","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101233_bib17","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101233_bib19","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1242\/jcs.02675","article-title":"The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling","volume":"118","author":"Pare","year":"2005","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2024.101233_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2022.07.007","article-title":"A perinuclear calcium compartment regulates cardiac myocyte hypertrophy","volume":"172","author":"Turcotte","year":"2022","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtm.2024.101233_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2005.07.030","article-title":"Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias","volume":"123","author":"Lehnart","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101233_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111468","article-title":"Identification of Novel Adenylyl Cyclase 5 (AC5) Signaling Networks in D(1) and D(2) Medium Spiny Neurons using Bimolecular Fluorescence Complementation Screening","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101233_bib23","doi-asserted-by":"crossref","first-page":"23540","DOI":"10.1074\/jbc.M109.030072","article-title":"An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes","volume":"284","author":"Kapiloff","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101233_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.15420\/cfr.2016:4:2","article-title":"Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective","volume":"2","author":"Lee","year":"2016","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.omtm.2024.101233_bib25","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1074\/jbc.M112.426957","article-title":"Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart","volume":"288","author":"DeGrande","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101233_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T11:04:12Z","timestamp":1726398252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2329050124000494"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101233","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101233"}}